A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine
NCT05685953
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
COVID-19 Respiratory Infection
COVID-19 Vaccine Adverse Reaction
Interventions
BIOLOGICAL:
DNA vaccine OC-007
OTHER:
Placebo
Sponsor
Matti Sällberg